BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent.
Business Wire (November 21, 2008)
Permanent Link:
http://vlex.com/vid/biomimetic-allowance-pdgf-compositions-57035550
Id. vLex: VLEX-57035550
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
BioMimetic Therapeutics, Inc. Announces Patent Allowance from United States Patent and Trademark Office for PDGF Compositions Patent.
Expanded protection for Augment[TM], Augment[TM] Injectable and GEM 21S([R]) until 2024
FRANKLIN, Tenn. -- BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today the United States Patent Office...Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
Other documents:
Colleges Briefly |
State Names Monroe Head Coach Former Yellow Jacket Defensive Coordinator Moves Int... |
City Honors First Carson Scholars |
Arret Cour d appel de Lyon N 06/01272 November 20 2007 |
Acórdão Inteiro Teor nº RR-731655/2001.2 of , of June 30, 2004
|
Acórdão nº 046243 of Supremo Tribunal Administrativo of January 31 2001
|
Banks and bank holding companies Meetings Sunshine Act,
|
Meetings:
Advisory Board,
|
gag on cwb removed |
Autelsi reconoce con sus premios a los líderes de las `telecos' |
Despacho N. 605/2004 de 3 de Agosto
|
acuerdo n 990081530872 of 13 camara de direito criminal, of january 22, 2009
|
Entscheidungstext 1Ob4/86 Oberster Gerichtshof March 17 1986
